Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Caspian Journal of Internal Medicine
|
September 7, 2013
Increased cefepime MIC for enterobacteriacae clinical isolates
Narges Najafi, Ahmad Alikhani, Farhang Babamahmoudi, et al.
Scientific Reports
|
November 10, 2021
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, et al.
Caspian Journal of Internal Medicine
|
August 3, 2022
Can cytokines response play a role in the treatment of fatal leptospirosis?
Ahmad Alikhani, Kimia Mahmoodi, Leyla Delavaryan, et al.
Biomed Research International
|
February 20, 2015
Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran
Farhang Babamahmoodi, Ahmad Alikhani, Jamshid Yazdani Charati, et al.
Caspian Journal of Internal Medicine
|
November 12, 2015
Epidemiological, clinical and laboratory features of patients hospitalized with 2009 pandemic influenza in north of Iran
Narges Najafi, Ali Reza Davoudi, Farhang Baba Mahmoodi, et al.
Journal of Infection in Developing Countries
|
February 4, 2020
Comparison of azithromycin vs doxycycline prophylaxis in leptospirosis, A randomized double blind placebo-controlled trial
Ahmad Alikhani, Ebrahim Salehifar, Fatemeh Zameni, et al.
Journal of Research in Pharmacy Practice
|
April 25, 2025
Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled Trial
Amir Mohammad Shabani, Ahmad Alikhani, Fatemeh Heydari, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
February 23, 2022
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial
Zahra Nekoukar, Shahram Ala, Siavash Moradi, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1
Said A Hassounah, Ahmad Alikhani, Maureen Oliveira, et al.
Scientific Reports
|
November 3, 2021
Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran
Farhang Babamahmoodi, Majid Saeedi, Reza Alizadeh-Navaei, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Caspian Journal of Internal Medicine
|
September 7, 2013
Increased cefepime MIC for enterobacteriacae clinical isolates
Narges Najafi, Ahmad Alikhani, Farhang Babamahmoudi, et al.
Scientific Reports
|
November 10, 2021
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, et al.
Caspian Journal of Internal Medicine
|
August 3, 2022
Can cytokines response play a role in the treatment of fatal leptospirosis?
Ahmad Alikhani, Kimia Mahmoodi, Leyla Delavaryan, et al.
Biomed Research International
|
February 20, 2015
Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran
Farhang Babamahmoodi, Ahmad Alikhani, Jamshid Yazdani Charati, et al.
Caspian Journal of Internal Medicine
|
November 12, 2015
Epidemiological, clinical and laboratory features of patients hospitalized with 2009 pandemic influenza in north of Iran
Narges Najafi, Ali Reza Davoudi, Farhang Baba Mahmoodi, et al.
Journal of Infection in Developing Countries
|
February 4, 2020
Comparison of azithromycin vs doxycycline prophylaxis in leptospirosis, A randomized double blind placebo-controlled trial
Ahmad Alikhani, Ebrahim Salehifar, Fatemeh Zameni, et al.
Journal of Research in Pharmacy Practice
|
April 25, 2025
Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled Trial
Amir Mohammad Shabani, Ahmad Alikhani, Fatemeh Heydari, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
February 23, 2022
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial
Zahra Nekoukar, Shahram Ala, Siavash Moradi, et al.
Antimicrobial Agents and Chemotherapy
|
September 20, 2017
Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1
Said A Hassounah, Ahmad Alikhani, Maureen Oliveira, et al.
Scientific Reports
|
November 3, 2021
Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran
Farhang Babamahmoodi, Majid Saeedi, Reza Alizadeh-Navaei, et al.
Page
of 3